The Cardiovascular Drug Discovery market is a subset of the pharmaceutical industry focused on the development of drugs to treat cardiovascular diseases. These drugs are used to treat a variety of conditions, including hypertension, coronary artery disease, congestive heart failure, and arrhythmias. The market is driven by the increasing prevalence of cardiovascular diseases, as well as the need for new and improved treatments.
The market is highly competitive, with a number of large pharmaceutical companies and smaller biotechnology companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, Sanofi, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Additionally, there are a number of smaller biotechnology companies that are developing innovative treatments for cardiovascular diseases. Show Less Read more
